Imatinib is a targeted therapy known as a tyrosine kinase inhibitor (TKI). It is primarily used in the treatment of various cancers, most notably chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). By inhibiting specific tyrosine kinases, imatinib disrupts the signaling pathways that promote the growth and proliferation of cancer cells.
